| MSGLX | WCMLX | MSGLX / WCMLX | |
| Total Expense Ratio | 1.15 | 0.99 | 116% |
| Annual Report Gross Expense Ratio | 1.15 | 1.79 | 64% |
| Fund Existence | 27 years | 6 years | - |
| Gain YTD | 5.820 | 6.454 | 90% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 100000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 589M | 41.9M | 1,406% |
| Annual Yield % from dividends | 0.00 | 0.00 | - |
| Returns for 1 year | -6.04 | -2.98 | 203% |
| Returns for 3 years | 28.20 | 22.89 | 123% |
| Returns for 5 years | -17.03 | 4.74 | -359% |
| Returns for 10 years | -9.72 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| LONZ | 50.52 | -0.05 | -0.10% |
| PIMCO Sr Ln Actv ETF | |||
| VWOB | 67.53 | -0.25 | -0.37% |
| Vanguard Emerging Mkts Govt Bd ETF | |||
| BTA | 9.50 | -0.06 | -0.63% |
| Blackrock Long-Term Municipal Advantage Trust | |||
| GLOW | 30.40 | -0.49 | -1.58% |
| VictoryShares WestEnd Global Equity ETF | |||
| BBC | 31.46 | -0.78 | -2.43% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||